HK1210593A1 - Tetracycline compounds for treating neurodegenerative disorders - Google Patents

Tetracycline compounds for treating neurodegenerative disorders

Info

Publication number
HK1210593A1
HK1210593A1 HK15111349.8A HK15111349A HK1210593A1 HK 1210593 A1 HK1210593 A1 HK 1210593A1 HK 15111349 A HK15111349 A HK 15111349A HK 1210593 A1 HK1210593 A1 HK 1210593A1
Authority
HK
Hong Kong
Prior art keywords
neurodegenerative disorders
tetracycline compounds
treating neurodegenerative
treating
tetracycline
Prior art date
Application number
HK15111349.8A
Other languages
English (en)
Chinese (zh)
Inventor
Todd Bowser
Paul Higgins
Michael P Draper
S Ken Tanaka
Original Assignee
Paratek Pharm Innc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paratek Pharm Innc filed Critical Paratek Pharm Innc
Publication of HK1210593A1 publication Critical patent/HK1210593A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15111349.8A 2012-07-13 2015-11-18 Tetracycline compounds for treating neurodegenerative disorders HK1210593A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261671587P 2012-07-13 2012-07-13
PCT/US2013/050495 WO2014012094A2 (fr) 2012-07-13 2013-07-15 Composés tétracycline destinés à traiter des troubles neurodégénératifs

Publications (1)

Publication Number Publication Date
HK1210593A1 true HK1210593A1 (en) 2016-04-29

Family

ID=49916712

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111349.8A HK1210593A1 (en) 2012-07-13 2015-11-18 Tetracycline compounds for treating neurodegenerative disorders

Country Status (7)

Country Link
US (1) US20150174144A1 (fr)
EP (1) EP2872146A4 (fr)
JP (1) JP2015525766A (fr)
AU (1) AU2013289892A1 (fr)
CA (1) CA2878462A1 (fr)
HK (1) HK1210593A1 (fr)
WO (1) WO2014012094A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (fr) 2007-11-30 2009-06-04 Foamix Ltd. Peroxyde de benzoyle contenant de la mousse
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
CA2760186C (fr) 2009-04-28 2019-10-29 Foamix Ltd. Vehicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
CA2769677A1 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
CA2769625C (fr) 2009-07-29 2017-04-11 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses legeres, et leurs utilisations
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
WO2020206321A1 (fr) * 2019-04-04 2020-10-08 Cmtx Biotech Inc. Procédés de traitement d'une maladie de charcot-marie-tooth

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US6613756B2 (en) * 2000-05-05 2003-09-02 Wisconsin Alumni Research Foundation Use of tetracycline derivatives in treating multiple sclerosis
EP3461808A1 (fr) * 2000-07-07 2019-04-03 Trustees of Tufts College Composés de minocycline substitués en position 9
AU2001288792A1 (en) * 2000-09-06 2002-03-22 Neurotherapeutics, Llc Method of treating neurologic disorders
US20030092683A1 (en) * 2001-11-13 2003-05-15 Yansheng Du Use of tetracyclines as neuro-protective agents and for the treatment of parkinson's disease and related disorders
WO2006084265A1 (fr) * 2005-02-04 2006-08-10 Paratek Pharmaceuticals, Inc. Derives 11a, 12 de composes de tetracycline
WO2006124537A1 (fr) * 2005-05-12 2006-11-23 The Burnham Institute Composes regulant l'apoptose
CA3051994A1 (fr) * 2006-12-21 2008-07-03 Paul Abato Composes de tetracycline substituee
US20100317715A1 (en) * 2007-12-21 2010-12-16 Vollrath Benedikt Methods for treating neuropsychiatric conditions
EP2307027A4 (fr) * 2008-07-11 2012-08-15 Neumedics Dérivés de tétracycline présentant une activité antibiotique réduite et des bénéfices neuroprotecteurs
CA2737470A1 (fr) * 2008-09-19 2010-03-25 Paratek Pharmaceuticals, Inc. Composes de tetracycline utilises dans le traitement de la polyarthrite rhumatoide et methodes therapeutiques associees

Also Published As

Publication number Publication date
EP2872146A2 (fr) 2015-05-20
WO2014012094A2 (fr) 2014-01-16
WO2014012094A3 (fr) 2014-03-06
AU2013289892A1 (en) 2015-02-19
CA2878462A1 (fr) 2014-01-16
EP2872146A4 (fr) 2016-01-06
US20150174144A1 (en) 2015-06-25
JP2015525766A (ja) 2015-09-07

Similar Documents

Publication Publication Date Title
HK1210593A1 (en) Tetracycline compounds for treating neurodegenerative disorders
EP2900330A4 (fr) Laquinimode et pridopidine pour traiter des troubles neurodégénératifs
IL266719A (en) Tetracycline compounds
IL253421B (en) Compounds for the treatment of fibrosis (Leifat)
PL2776055T3 (pl) Sposoby leczenia zaburzeń żołądkowo-jelitowych
IL235317A0 (en) A compound for the treatment of metabolic disorders
IL237483A0 (en) Preparations for the treatment of psoriasis
IL221415A0 (en) Compounds useful for treating neurodegenerative disorders
GB2499668B (en) Exposure controller
HK1219224A1 (zh) 角結膜病症的治療劑
GB201010359D0 (en) Compounds for treating proliferative disorders
ZA201503005B (en) Ingenol-derived compounds useful for treating cancer
EP2861242A4 (fr) Troubles associés au gluten
EP2723339A4 (fr) Composés pour le traitement de neuropathies périphériques et d'autres troubles neurodégénératifs
EP2908813A4 (fr) Composés permettant de traiter un trouble médié par la rac-gtpase
PL2617412T3 (pl) Kompozycja do leczenia miejscowego
GB201215358D0 (en) Grating apparatus
AU2012904982A0 (en) Device for treating respiratory disorders
GB201009495D0 (en) Compounds for treating proliferative disorders
GB201101183D0 (en) Treatment of neurodegenerative disorders
GB201207363D0 (en) Compounds for the treatment of metabolic disorders
GB201207359D0 (en) Compounds for the treatment of metabolic disorders